Details for 2021186643

Up to date per 01.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON ETHYL((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUOR-2,5-DIHYDROFURAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)-L-ALANINAT (GS-9131) VANILLATE ZUR BEHANDLUNG VON VIRUSINFEKTIONEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2021186643

EP Publication Number

3960740

E-Number

1631696

Language

PCT Number

Publication Date

02.03.2022 A

15.11.2023 B1

Registration Date

15.11.2023

AT Publication Date

15.12.2023

Application Date

30.07.2018

Registration Number

Priorities

01.08.2017

201762539822 P

IPC

C07D 417/12 20060101AFI20230426BHEP

Maximum Duration of Protection

30.07.2038

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

Representative

No representatives present

Inventor

LAPINA, Olga Viktorovna Foster City, 94404US

SHI, Bing Foster City, 94404US

WANG, Silas Foster City, 94404US